Award notice, first published as presolicitation
Rituximab Effective 09/15/2025 - 09/14/2026
36E79725R0021
Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.
Awarded
$0.00 obligated so far on USAspending
Get the next one like this from Department of Veterans Affairs by email, the day it is posted.Find my opportunities
This one was awarded in 2025
9 like it are open now in pharmaceutical preparation manufacturing
- Sacubitril/Valsartan Tablets (VA-27-00014055)
Department of Veterans Affairs, Nac Pharmaceuticals
PresolicitationNAICS 325412Anywhere in the US36E79727R0007Closes in 2 daysNov 3 - Methylphenidate ER
Defense Logistics Agency, DLA Troop Support
SolicitationNAICS 325412Anywhere in the USSPE2D226R0013Closes in 5 daysNov 6 - FY27 Lenalidomide BPA
Department of Veterans Affairs, 262-Network Contract Office 22
Sources soughtNAICS 325412Anywhere in the US36C26227Q0083Closes in 11 daysNov 12
Description
As published on SAM.gov with the solicitation of February 13, 2025.
Rituximab
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Pfizer Inc.
- UEI
- MHBQULRMEEJ5
- CAGE
- 86491
- Vendor location
- New York, NY
- Contract
- 36E79725D0032
- Obligated
- $0.00, potential $74,038,217
- Actions
- 5 between April 29, 2025 and September 2, 2026
- Competition
- Full and Open Competition, 2 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- New Award for Rituximab with Pfizer INC. Base Year Ordering Period Is September 15, 2025 to September 14, 2026 with Four ONE-YEAR Options.
- Match
- award number 36E79725D0032 equals the contract number; same awarding office 36E797 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
January 28, 2025
Presolicitation
Rituximab and Biosimilars
Due February 14, 2025 at 3:30 PM EST. SAM.gov, notice f54810a5b77f424297b8eb9d6097413f
February 10, 2025
Solicitation, originally presolicitation
Rituximab and Biosimilars
Due March 4, 2025 at 3:30 PM EST. SAM.gov, notice cd8e8fc27b3f41d39462038592416ea1
February 13, 2025
Solicitation
Rituximab and Biosimilars
Due March 11, 2025 at 3:30 AM EDT. SAM.gov, notice 60656e591de34a70a8ec8be73cd36547
April 29, 2025
Award notice
Awarded to Pfizer Inc. New York 10001 for $74,038,217. SAM.gov, notice bf70e13c1f034cf3af08f4cc0609fd75
Points of contact
- Deb Fassl, Contract SpecialistDeborah.Fassl@va.gov708-786-5894